Pharma Reps Slam PTAB Over 'Skewed' Procedural Rules
Pharmaceutical industry representatives slammed the Patent Trial and Appeal Board on Tuesday, saying its current process is tipped too far in favor of patent challengers and doesn't adequately account for industry...To view the full article, register now.
Already a subscriber? Click here to view full article